nach oben

American Journal of Clinical Dermatology

Erschienen in:

01.10.2014 | Review Article

Treatment of Pediculosis Capitis: A Critical Appraisal of the Current Literature

verfasst von: Hermann Feldmeier

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Pediculosis capitis is the most common ectoparasitic disease in children in industrialized countries and extremely common in resource-poor communities of the developing world. The extensive use of pediculicides with a neurotoxic mode of action has led to the development and spread of resistant head lice populations all over the world. This triggered the development of compounds with other modes of action. The current literature on treatment approaches of head lice infestation was searched, and published randomized controlled trials were critically analyzed. The following compounds/family of compounds were identified: spinosad, a novel compound with a new neurotoxic mode of action, isopropyl myristate, 1,2-octanediol, ivermectin, plant-based products, and dimeticones. The efficacy and safety of these compounds are reviewed and recommendations for the treatment of pediculosis capitis in individuals as well as the interruption of ongoing epidemics are provided.

Jahnke C, Bauer E, Feldmeier H. Pediculosis capitis im Kindesalter: epidemiologische und sozialmedizinische Erkenntnisse einer Reihenuntersuchung von Schulanfängern. Gesundheitswesen. 2008;70(11):667–73.PubMedCrossRef

Rukke BA, Birkemoe T, Soleng A, Heggen-Lindstedt H, Ottesen P. Head lice prevalence among households in Norway; importance of spatial variables and individual and household characteristics. Parasitology. 2011;138:1296–304.PubMedCrossRefPubMedCentral

Feldmeier H, Heukelbach J. Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues. Bull World Health Org. 2009;87(2):152–9.PubMedCrossRefPubMedCentral

Feldmeier H. Pediculosis capitis: new insights into epidemiology, diagnosis and treatment. Eur J Clin Microbiol Infect Dis. 2012;31:2105–10.PubMedCrossRef

Lesshafft H, Baier A, Guerra H, Terashima A, Feldmeier H. Prevalence and risk factors associated with pediculosis capitis in an impoverished urban community in Lima, Peru. J Global Infect Dis. 2013;5(4):138–42.CrossRef

Falagas ME, Matthaiou DK, Rafailidis PI, Panos G, Pappas G. Worldwide prevalence of head lice. Emerg Infect Dis. 2008;14(9):1493–4.PubMedCrossRefPubMedCentral

Vassena CV, MougabureCueto GA, Alzogaray RA, Zerba EN, Picollo MI. Prevalence and levels of permethrin resistance in Pediculus humanus capitis De Geer (Anoplura: Pediculidae) from Buenos Aires, Argentina. J Med Entomol. 2003;40:447–50.PubMedCrossRef

Kasai S, Ishii N, Natsuaki M, Fukutomi H, Komagata O, Kobayashi M, Tomita T. Prevalence of kdr-like mutations associated with pyrethroid resistance in human head louse populations in Japan. J Med Entomol. 2009;46(1):77–82.PubMedCrossRef

Durand R, Millard B, Bouges-Michel C, Bruel C, Bouvresse S, Izri A. Detection of pyrethroid resistance gene in head lice in schoolchildren from Bobigny, France. J Med Entomol. 2007;44:796–7.PubMedCrossRef

10.

Kristensen M, Knorr M, Rasmussen AM, Jespersen JB. Survey of permethrin and malathion resistance in human head lice populations from Denmark. J Med Entomol. 2006;43:533–8.PubMedCrossRef

11.

Yoon KS, Gao JR, Lee SH, Clark JM, Brown L, Taplin D. Permethrin resistant human head lice, Pediculus capitis, and their treatment. Arch Dermatol. 2003;139:994–1000.PubMedCrossRef

12.

Barker SC, Burgess IF, Terri L, Meinking TL, Mumcuoglu KY. International guidelines for clinical trials with pediculocides. Int J Dermatol. 2012;51:853–8.PubMedCrossRef

13.

Feldmeier H, Jahnke C. Pediculosis capitis: epidemiologie, diagnose und therapie. Pädiatrische Praxis. 2010;76:359–70.

14.

Jahnke C, Bauer E, Hengge U, Feldmeier H. Accuracy of diagnosis of pediculosis capitis: visual inspection versus wet combing. Arch Dermatol. 2009;145:309–13.PubMedCrossRef

15.

Pickett MM, Muszynski MA, Norton S. Of Lice and Men. JAMA Dermatol. 2014;150(3):250.PubMedCrossRef

16.

Veracx A, Raoult D. Biology and genetics of human head and body lice. Trends Parasitol. 2012;28:563–71.PubMedCrossRef

17.

Parola P, Fournier PE, Raoult D. Bartonella quintana, lice, and molecular tools. J Med Entomol. 2006;43:787.PubMedCrossRef

18.

Light JE, Allen JM, Long LM, Carter TE, Barrow L, Suren G, Raoult D, Reed DL. Geographic distributions and origins of human head lice (Pediculus humanus captitis) based on mitochondrial data. J Parasitol. 2008;94(6):1275–81.PubMedCrossRef

19.

Boutellis A, Medlannikov O, Bilcha KD, Ali J, Campelo D, Barker SC, Raoult D. Borrelia recurrentis in head lice, Ethiopia. Emerg Infect Dis. 2013;19:796–8.PubMedPubMedCentral

20.

Angelakis E, Diatta G, Abdissa A, Trape JF, Mediannikov O, Richet H, Raoult D. Altitude-dependent Bartonella quintana genotype C in head lice, Ethiopia. Emerg Infect Dis. 2011;17(12):2357–9.PubMedCrossRefPubMedCentral

21.

Feldmeier H. Lice as vectors of pathogenic microorganisms. In: Heukelbach J, editor. Management and control of head lice infestation. Bremen: UNIMED; 2010. p. 132–5.

22.

Do-Pham G, Le Cleach L, Giraudeau B, Maruani A, Chosidow O, Ravaud P. Designing randomized-controlled trials to improve head louse treatment: systematic review using a vignette-based method. J Investig Dermatol. 2014;134:628–34.PubMedCrossRef

23.

Sonnberg S, Oliveira FA, de Melo ILA, de Melo Soares MM, Becher H, Heukelbach J. Ex vivo development of eggs from head lice (Pediculus humanus capitis). Open Dermatol J. 2010;4:82–9.

24.

Strycharz JP, Lao AR, Alves A, Clark JM. Ovicidal respone of NYDA formulations on the human head louse (Anoplura: PEdiculidae) using a hair tuft bioassay. Lanham: Entomological Society of America; 2012.

25.

Elston DM. Drug-resistant lice. Arch Dermatol. 2003;139:1061–4.PubMedCrossRef

26.

Picollo MI, Vassena CV, Mougabure Cueto GA, Vernetti M, Zerba E. Resistance to insecticides and effect of synergesis on permethrin toxicity in Pediculus capitis (Anoplura: Pediculidae) from Buenos Aires. J Med Entomol. 2000;37:721–5.PubMedCrossRef

27.

Bailey AM, Provic P. Persistent head lice following multiple treatments: evidence for insecticide resistance in Pediculus humanus capitis. Australas J Dermatol. 2000;41:250–4.PubMedCrossRef

28.

Hunter JA, Barker SC. Susceptibility of head lice (Pediculus humanus capitis) to pediculicides in Australia. Parasitol Res. 2003;90:476–8.PubMedCrossRef

29.

Burgess IF, Kay K, Burgess NA, Brunton ER. Soya oil-based shampoo superior to 0.5 % permethrin lotion for head louse infestation. Med Devices Evid Res. 2011;4(4):35–42.CrossRef

30.

Burgess IF, Lee PN, Brown CM. Randomised, controlled, parallel group clinical trials to evaluate the efficacy of isopropyl myristate/cyclomethicone solution against head lice. Pharm J. 2008;280:371–5.

31.

Burgess IF, Brunton ER, Burgess NA. Clinical trial showing superiority of a coconut and anise spray over permethrin 0.43 % lotion for head louse infestation, ISRCTN96469780. Eur J Pediatr. 2010;169:55–62.PubMedCrossRef

32.

Burgess IF, Brunton ER, Burgess NA. Single application of 4 % dimeticone liquid gel versus two applications of 1 % permethrin creme rinse for treatment of head louse infestation: a randomised controlled trial. BMC Dermatol. 2013;13:5. doi:10.1186/1471-5945-13-5.PubMedCrossRefPubMedCentral

33.

van der Stichele RHV, Dezeure EM, Bogaert MG. Systematic review of clinical efficacy of topical treatments for head lice. BMJ. 1998;311:604–8.CrossRef

34.

Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation with 4 % dimeticone lotion: randomised controlled equivalence trial. BMJ. 2005;330:1423–6.PubMedCrossRefPubMedCentral

35.

Plastow L, Luthra M, Powell R, Wright J, Russel D, Marshall MN. Head lice infestation: bug busting vs. traditional treatment. J Clin Nurs. 2001;10:775–83.PubMedCrossRef

36.

Willems S, Lapeere H, Haedens N, Pasteels I, Naeyaert JM, De Maeseneer J. The importance of socio-economic status and individual characteristics on the prevalence of head lice in schoolchildren. Eur J Dermatol. 2005;15(5):387–92.PubMed

37.

Tomalik-Scharte D, Lazar A, Meins J, Bastian B, Ihrig M, Wachall B, Jetter A, Tantcheva-Poor I, Mahrle G, Fuhr U. Dermal absorption of permethrin following topical administration. Eur J Clin Pharmacol. 2005;61(5–6):399–404.PubMedCrossRef

38.

Anonymous Topische Therapie bei Kopfläusen. Der Arzneimittelbrief. 2009;43:81–86.

39.

Menegaux F, Baruchel A, Bertrand Y, Lescoeur B, Leverger G, Nelken B, Sommelet D, Hémon D, Clavel C. Household exposure to pesticides and risk of childhood leukaemia. Occup Environ Med. 2006;63(2):131–4.PubMedCrossRefPubMedCentral

40.

Stough D, Shellabarger S, Quiring J, Gabrielsen AA Jr. Efficacy and safety of spinosad and permethrin creme rinses for Pediculosis capitis (head lice). Pediatrics. 2009;124(3):389–95.CrossRef

41.

Heukelbach J, Canyon DV, Heukelbach-Oliveira F, Muller R, Spear RC. In vitro efficacy of over-the-counter botanical pediculicides against the head louse Pediculus humanus var capitis based on a stringent standard for mortality assessment. Med Vet Entomol. 2008;22:262–74.CrossRef

42.

Heukelbach J, Canyon DV, Speare R. The effect of natural products on head lice: in vitro tests and clinical evidence. J Pediatr Infect Dis. 2007;2:67–76.

43.

Strycharz JP, Yoon KS, Clark JM. A new ivermectin formulation topically kills permethrin-resistant human head lice (Anoplura: Pediculidae). J Med Entomol. 2008;45(1):75–81.PubMedCrossRef

44.

Barnett E, Palma KG, Clayton B, Ballard T. Effectiveness of isopropyl myristate cylcomethicone of removing cuticular hydrocarbons from human head lice. BMC Dermatol. 2012;12:15. doi:10.1186/1471-5945-12-15.PubMedCrossRefPubMedCentral

45.

Kaul N, Palma KG, Silagy SS, Goodman JJ, Toole J. North American efficacy and safety of a novel pediculicide rinse, isopropyl myristate 50 % (Resultz). J Cutan Med Surg. 2007;11(5):161–7.PubMed

46.

Burgess IF, Lee PN, Kay K, Jones R, Brunton ER. 1,2-Octanediol, a novel surfactant, for treating headlouse infestation: identification of activity, formulation, and randomised, controlled trials. PLoS One. 2012;7(4):e35419.PubMedCrossRefPubMedCentral

47.

Burgess IF, Brunton ER, French R, Burgess NA. Prevention of head louse infestation: a randomised, double-blind, cross-over study of a novel concept product, 1 % 1,2-octanediol spray versus placebo. BMJ Open. 2014;4(5):e004634.PubMedCrossRefPubMedCentral

48.

Feldmeier H. Pediculosis capitis: Eine Herausforderung für das Apothekerteam. PTA-Forum. 2013;11:22–6.

49.

Heukelbach J, Oliveira FA, Richter J, Häussinger D. Dimeticone-based pediculicides: a physical approach to eradicate head lice. Open Dermatol J. 2010;4:77–81.

50.

Burgess IF. The mode of action of dimeticone 4 % lotion against head lice, Pediculus capitis. BMC Pharmacol. 2009;9:3. doi:10.1186/1471-2210-9-3.PubMedCrossRefPubMedCentral

51.

Richling I, Böckeler W. Lethal effects of treatment with a special dimeticone formula on head lice and house crickets (Orthoptera, Ensifera: Acheta domestica and Anoplura, Phthiraptera: Pediculus humanus). Arzneim-Forsch/Drug Res. 2008;58:248–54.

52.

Heukelbach J, Pilger D, Oliveira F, Khakban A, Ariza L, Feldmeier H. A highly efficacious pediculocide based on dimeticone: randomized observer blinded comparative trial. BMC Infect Dis. 2008;8:115. doi:10.1186/1471-2334-8-115.PubMedCrossRefPubMedCentral

53.

Heukelbach J, Sonnberg S, Becher H, Melo I, Speare R, Oliveira FA. Ovicidal efficacy of high concentration dimeticone: a new era of head lice treatment. J Am Acad Dermatol. 2011;64(4):e61–2.PubMedCrossRef

54.

Nair B. Final report on the safety assessment of stearoxy dimethicone, dimethicone, methicone, amino bispropyl dimethicone, aminopropyl dimethicone, amodimethicone, amodimethicone hydroxystearate, behenoxy dimethicone, C24-28 alkyl methicone, C30-45 alkyl methicone, C30-45 alkyl dimethicone, cetearyl methicone, cetyl dimethicone, dimethoxysilyl ethylenediaminopropyl dimethicone, hexyl methicone, hydroxypropyldimethicone, stearamidopropyl dimethicone, stearyl dimethicone, stearyl methicone, and vinyldimethicone. Int J Toxicol. 2003;22:11–35.PubMed

55.

Lapeere H, Brochez L, Verhaeghe E, Vander-Stichele RH, Remon JP, Lambert J, Leybaert L. Efficacy of products to remove eggs of Pediculosis humanus capitis (Phthiraptera: Pediculidae) from the human hair. J Med Entomol. 2014;51(2):400–7.PubMedCrossRef

56.

Meinking TL, Mertz-Rivera K, Villar ME, Bell M. Assessment of the safety and efficacy of three concentrations of topical ivermectin lotion as a treatment for head lice infestation. Int J Dermatol. 2013;52:106–12.PubMedCrossRef

57.

Dornseiff M, Schwartz T. Randomisierte, Untersucher-verblindete kontrollierte, multizentrische Therapiestudie mit Dodecanol plus Demeticon (Dimet^® 20*) versus Dimeticon-Mono bei Kopflausbefall—Integrierter Abschlussbericht. 2010. http://www.infectopharm.com/login?ref=/egi-bin/dl.pl/downloads/dimet20studie_2010.pdf. Assessed 21 July 2014.

58.

Deeks LS, Naunton M, Currie MJ, Bowden FJ. Topical ivermectin 0.5 % lotion for treatment of head lice. Ann Pharmacother. 2013;47(9):1161–7.PubMedCrossRef

59.

Burgess I. Head lice. Clin Evid (Online). 2011;05:pii:1703.

60.

Laguna MF, Risau-Gusman S. Of lice and math: using models to understand and control populations of head lice. Plos One. 2011;6(7):e21848. doi:10.1371/journal.pone.0021848.PubMedCrossRefPubMedCentral

61.

Greive KA, Lui AH, Barnes TM, Oppenheim VM. Safety and efficacy of a non-pesticide-based head lice treatment: results of a randomised comparative trial in children. Australas J Dermatol. 2012;53(4):255–63.PubMedCrossRef

62.

Mumcuoglu KY, Miller J, Zamir C, Zentner G, Helbin V, Ingber A. The in vivo pediculicidal efficacy of a natural remedy. IMAJ. 2002;4(10):790–2.PubMed

63.

Barker SC, Altman PM. A randomised, assessor blind, parallel group comparative efficacy trial of three products for the treatment of head lice in children-melaleuca oil and lavender oil, pyrethrins and piperonyl butoxide, and a “suffocation” product. BMC Dermatol. 2010;10:6. doi:10.1186/1471-5945-10-6.PubMedCrossRefPubMedCentral

64.

Chosidow O, Giraudeau G, Cottrell J, Izri A, Hofmann R, Mann SG, Burgess IF. Oral ivermectin versus malathion lotion for difficult-to-treat head lice. N Engl J Med. 2010;362(10):896–905.PubMedCrossRef

65.

Pariser DM, Meinking TL, Bell M, Ryan WG. Topical 0.5 % ivermectin lotion for treatment of head lice. N Engl J Med. 2012;367(18):1687–93.PubMedCrossRef

66.

Nofal A. Orales ivermectin gegen Kopfläuse: ein Vergleich mi 0,5 % topischer Malathionlotion. JDDG. 2010;8(12):985–9.PubMed

67.

Pilger D, Heukelbach J, Khakban A, de Oliveiera FAS, Fengler G, Feldmeier H. Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer-blinded controlled trial. Bull World Health Org. 2010;88:90–6. doi:10.2471/BLT.08.051656):90-96.PubMedCrossRefPubMedCentral

68.

Burgess IF, Lee PN, Matlock G. Randomised, controlled, assessor blind trial comparing 4 % dimeticone lotion with 0.5 % malathion liquid for head lice infestation. PLoS One. 2007;11:e1127.CrossRef

69.

Kurt O, Balcioglu C, Burgess IF, Limoncu ME, Girginkardesler N, Tabak T, Muslu H, Ermis O, Sahin MT, Bilac C, Kavur H, Ozbel Y. Treatment of head lice with dimeticone 4 % lotion: comparison of two formulations in a randomised controlled trial in rural Turkey. BMC Public Health. 2009;9:441.PubMedCrossRefPubMedCentral

Titel: Treatment of Pediculosis Capitis: A Critical Appraisal of the Current Literature
verfasst von: Hermann Feldmeier
Publikationsdatum: 01.10.2014
Verlag: Springer International Publishing
Erschienen in: American Journal of Clinical Dermatology / Ausgabe 5/2014
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI: https://doi.org/10.1007/s40257-014-0094-4

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Treatment of Pediculosis Capitis: A Critical Appraisal of the Current Literature

Abstract

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Imiquimod in the Treatment of Cutaneous Warts: An Evidence-Based Review

Biologic Therapy with or Without Topical Treatment in Psoriasis: What Does the Current Evidence Say?

Neutrophilic Dermatoses: An Update

Neonatal Junctional Epidermolysis Bullosa: Treatment Conundrums and Ethical Decision Making

Dermatological Toxicity Associated with Targeted Therapies in Cancer: Optimal Management

Relationship Between Helicobacter pylori Infection and Vitiligo: A Prospective Study

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie